Eli Lilly And Co vs Invesco Solar ETF — how do they compare? Eli Lilly And Co trades at $1,205.55 (market cap $1.08T), while Invesco Solar ETF trades at $53.25. The key difference: Eli Lilly And Co pays a 0.57% dividend while Invesco Solar ETF pays none. Which is the better fit depends on your goals.
| LLY | TAN | |
|---|---|---|
Market Cap | $1.08T | — |
Sector | Health | Sector/Thematic |
52-Week High | $1.24K | $73.95 |
52-Week Low | $639.43 | $36.62 |
Enterprise Value | $1.13T | — |
Dividend Yield | 0.57% | — |
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,231.58, up 3.87% in the past 24 hours, reflecting strong momentum near its 52-week high. The stock exhibits bullish technical signals with robust fundamentals, including 48% revenue growth in Q2 2026 and a net income margin of 33.53%. Recent news highlights legal actions against black-market drug sales and positive analyst sentiment following earnings beats.
Outlook remains positive with a consensus price target of $1,380, though high valuation ratios (P/E 40.79) and regulatory risks pose challenges. Earnings growth and pipeline advancements, like retatrutide, drive upside potential, but investors should monitor competitive pressures and execution risks.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →TAN is a thematic ETF that tracks the MAC Global Solar Energy Index. It provides targeted exposure to the global solar industry, including manufacturers of solar panels, installers, and component suppliers like Enphase and First Solar.
Read more on TAN →